Laurus Labs Share Price Today | Stock Price & Laurus Labs Share Screener

Track the current stock price of Laurus Labs with an interactive chart. Analyse LAURUSLABS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Laurus Labs stock quote in one place.

The quote of ₹2,002.50 sits between the 52-week low of ₹926.40 and the 52-week high of ₹2,069.20, and the latest session moved -0.50% from the previous close.

Screen Laurus Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for LAURUSLABS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with Ravindranath Kancherla listed as chairperson or CEO, and it trades under ISIN INE947Q01028.

Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company based in India. It operates in four business lines: Generics - APIs, Generics - FDFs, Synthesis, and Ingredients. The company specializes in active pharmaceutical ingredients (APIs) for anti-retrovirals, Hepatitis C, and Oncology, among other therapeutic areas. Laurus Labs...more

Classification

Identifiers and Leadership

Screen LAURUSLABS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹10,511, up from ₹9,336 in 2025.

Latest statistics put total assets at ₹10,511 and shareholder funds at ₹5,431, with a leverage ratio of 0.54.

Screen Laurus Labs income statement and profit fundamentals. Analyze LAURUSLABS quarterly results. Laurus Labs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹2,036 and net profit was ₹362, equal to earnings per unit of ₹6.81, at an operating margin of 32%.

In that period expenses were ₹1,388, interest cost ₹42 and tax ₹119. The next period listed, 2026-Mar, shows revenue of ₹1,823 and net profit of ₹282.

Screen LAURUSLABS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1,624, and net cash flow was an inflow of ₹13.

Over the same period, investing activities used ₹1,086 and financing activities used ₹525.

See Laurus Labs shareholding pattern with promoter, FII, and DII holdings. Check Laurus Labs promoter holding and ownership changes for LAURUSLABS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 27.49%, foreign institutions 25.82%, domestic institutions 13.97% and the public 21.24%, spread across 292,281 shareholders.

The shareholder count was 292,281 in 2026-Mar, compared with 291,653 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Laurus Labs. Laurus Labs dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.00 per unit for 2026-March, a yield of 0.10%, compared with ₹1.20 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.00, ₹1.20 and ₹0.80 per unit.

See which indices include Laurus Labs stock. Check LAURUSLABS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 20 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX BSEMOI.

Get Laurus Labs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Laurus Labs stock events that may affect LAURUSLABS share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 29, 2026, with a record date of October 29, 2026.

It is followed by Quarterly Result Announcement dated July 24, 2026 and Annual General Meeting dated July 2, 2026.

Screen LAURUSLABS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen LAURUSLABS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 18, 2026.

The next most recent announcements are dated October 18, 2026 and October 17, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 23, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.